Suggested Topics within your search.
Suggested Topics within your search.
- Cancer 1
- Immune System 1
- Immunity 1
- Orthopedic surgery 1
- Orthopedics 1
- Pediatrics 1
- Tumors 1
-
1701
Three‐Dimensional Printed Prosthesis Reconstructs Bilateral Type III Pelvic Defect After Malignant Tumors Resection
Published 2025-01-01Subjects: Get full text
Article -
1702
Exploring the optimal reconstruction strategy for Enneking III defects in pelvis bone tumors: a finite element analysis
Published 2025-01-01Subjects: “…Pelvis bone tumors…”
Get full text
Article -
1703
Sentinel lymph nodes biopsy for malignant tumors using Technefit radioactive colloid Technetium 99mTc
Published 2024-12-01“…The first trial included Technefit intradermal-hypodermal injection into one point above the tumor node, RPP activity of 75 to 200 mBq at a room temperature of 21°C, without preliminary anesthesia with Novocain solution. …”
Get full text
Article -
1704
Structured reporting of neuroendocrine tumors in PET/CT using [18F]SiTATE - impact on interdisciplinary communication
Published 2025-02-01Subjects: “…Neuroendocrine tumor…”
Get full text
Article -
1705
Kinetic Analysis of 2-[C]Thymidine PET Imaging Studies of Malignant Brain Tumors: Preliminary Patient Results
Published 2002-07-01“…2-[ 11 C]Thymidine (TdR), a PET tracer for cellular proliferation, may be advantageous for monitoring brain tumor progression and response to therapy. Kinetic analysis of dynamic TdR images was performed to estimate the rate of thymidine transport ( K 1t ) and thymidine flux ( K TdR ) into brain tumors and normal brain. …”
Get full text
Article -
1706
Inhalable nanovesicles loaded with a STING agonist enhance CAR-T cell activity against solid tumors in the lung
Published 2025-01-01“…Abstract Suppression of chimeric antigen receptor-modified T (CAR-T) cells by the immunosuppressive tumor microenvironment remains a major barrier to their efficacy against solid tumors. …”
Get full text
Article -
1707
Optimal Timing for Resuming Antithrombotic Agents and Risk Factors for Delayed Bleeding after Endoscopic Resection of Colorectal Tumors
Published 2014-01-01“…We investigated (1) patient-factors: resuming antithrombotic agents within 5 days following endoscopic resection, hypertension, and diabetes mellitus; and (2) tumor-factors: morphology, size, location, and resection technique by conditional logistic regression. …”
Get full text
Article -
1708
Technetium 99m–Labeled VQ Peptide: A New Imaging Agent for the Early Detection of Tumors or Premalignancies
Published 2013-07-01“…The biodistribution in the HT-29 tumor model showed that although the absolute tumor uptake values were relatively low (0.60 ± 0.09, 0.41 ± 0.09, 0.36 ± 0.18, and 0.19 ± 0.08 %ID/g at 0.5, 1, 2, and 4 hours postinjection, respectively), the tumor uptake was higher than that of any of the other organs except for the kidneys at any time point examined, which led to the high tumor to nontarget ratios. …”
Get full text
Article -
1709
-
1710
Ultrasound and histopathological assessment of benign, borderline, and malignant thyroid tumors in pediatric patients: an illustrative review and literature overview
Published 2025-01-01“…Benign nodules like dyshormonogenetic goiter showed solid hypoechoic features on ultrasound and dense fibrosis on histopathology, while thyroid follicular nodular disease exhibited isoechoic nodules with halos, histologically revealing dilated follicles. In borderline tumors, well-differentiated tumor of uncertain malignant potential (WDT-UMP) nodules were hypo/hyperechoic with occasional capsular invasion, resembling papillary thyroid carcinoma (PTC) features histologically. …”
Get full text
Article -
1711
-
1712
Degenerated (Ancient) Schwannomas: Unraveling Unusual Locations and Treatment Management
Published 2024-04-01Subjects: Get full text
Article -
1713
The XIAP inhibitor AZD5582 improves the treatment effect of microwave ablation on hepatocellular carcinoma
Published 2025-01-01Subjects: Get full text
Article -
1714
Melanoma-derived cytokines and extracellular vesicles are interlinked with macrophage immunosuppression
Published 2025-01-01Subjects: “…tumor-promoting macrophage…”
Get full text
Article -
1715
Cancer vaccines: platforms and current progress
Published 2025-01-01Subjects: Get full text
Article -
1716
Clinical characteristics of EGFR-ctDNA shedders in EGFR-mutant NSCLC patients
Published 2025-02-01Subjects: “…Circulating-tumor DNA…”
Get full text
Article -
1717
Highly Stable Antitumor Silver-Lipid Nanoparticles Optimized for Targeted Therapy
Published 2025-02-01Subjects: Get full text
Article -
1718
Microultrasound Molecular Imaging of Vascular Endothelial Growth Factor Receptor 2 in a Mouse Model of Tumor Angiogenesis
Published 2007-09-01“…High-frequency microultrasound imaging of tumor progression in mice enables noninvasive anatomic and functional imaging at excellent spatial and temporal resolution, although microultrasonography alone does not offer molecular scale data. …”
Get full text
Article -
1719
Expression of EZH2 and H3K27me3 predicts tumor biology of urothelial carcinoma
Published 2023-07-01“…Results: EZH2 showed a significant correlation with the tumor grade and lamina propria invasion (p < 0.001). …”
Get full text
Article -
1720
Shedding Light on the Prognostic and Predictive Value of Circulating Tumor DNA for Management of Patients with Early-Stage Colon Cancer
Published 2025-01-01“…The management of early-stage colon cancer involves surgical resection of the primary tumor with or without chemotherapy, depending on pathological staging. …”
Get full text
Article